Browser Compatibility

Internet Explorer
Image
Not compatible
Google Chrome
Image
Compatible
Safari
Image
Compatible
Firefox
Image
Compatible
Opera
Image
Compatible
KCCC_Logo
Our Partners

The Ministry Of Health in the State of Kuwait collaborates with other entities to provide clinical expertise to Kuwait Cancer Control Center (KCCC) and strengthen cancer service delivery at the KCCC. Through this collaboration, KCCC offers our patients an access to the best internationally-certified cancer services, while ensuring continuous improvement of cancer care in Kuwait. We also focus on improving nursing and physician education, health administration and information technology. We continue to expand our experience while developing systems and innovative approaches that would benefit our patients.

For Professionals

Restricted Access !

Explore KCCC's resources and see our professional side to get the most updated administrative documents.

Esophagogastric Junction and Gastric Cancers
Chemoradiation

  • Preoperative chemoradiation is the preferred approach for localized adenocarcinoma of the thoracic esophagus or EGJ. Perioperative chemotherapy is an alternative option for distal esophagus and EGJ.


Locally Advanced, Recurrent or Metastatic Disease

  • Systemic therapy regimens for advanced esophageal and esophagogastric junction (EGJ) adenocarcinoma, squamous cell carcinoma of the esophagus, and gastric adenocarcinoma should be chosen in the context of performance status (PS), comorbidities, and toxicity profile.
  • Trastuzumab should be added to chemotherapy for HER2 overexpressing metastatic adenocarcinoma.
  • Two-drug regimens are preferred for patients with advanced disease because of lower toxicity. Three-drug cytotoxic regimens should be reserved for medically t patients with good PS and access to frequent toxicity evaluation.

Colorectal Cancers
Adjuvant

Unresectable Locally Advanced, Recurrent or Metastatic Disease
Pancreatic Cancer

Systemic therapy is used in all stages of pancreatic cancer, including neoadjuvant (resectable or borderline resectable), adjuvant, locally advanced unresectable, and metastatic disease.

Anal Cancer
© 2017 Kuwait Cancer Control Center